Dynavax Technologies
DVAX
#5494
Rank
NZ$2.22 B
Marketcap
NZ$18.98
Share price
-0.09%
Change (1 day)
-13.77%
Change (1 year)

Dynavax Technologies (DVAX) - Total assets

Total assets on the balance sheet as of September 2025 : NZ$1.63 Billion

According to Dynavax Technologies 's latest financial reports the company's total assets are NZ$1.63 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Dynavax Technologies - Total assets on balance sheet (from 2003 to 2025)

Total assets by year

Year Total assets Change
2024-12-31NZ$1.74 B10.91%
2023-12-31NZ$1.57 B1.54%
2022-12-31NZ$1.55 B2.06%
2021-12-31NZ$1.52 B210.76%
2020-12-31NZ$0.48 B18.16%
2019-12-31NZ$0.41 B31.8%
2018-12-31NZ$0.31 B2.05%
2017-12-31NZ$0.30 B94.56%
2016-12-31NZ$0.15 B-49.98%
2015-12-31NZ$0.31 B79.33%
2014-12-31NZ$0.17 B-29.12%
2013-12-31NZ$0.24 B46.57%
2012-12-31NZ$0.16 B-1.13%
2011-12-31NZ$0.17 B57.34%
2010-12-31NZ$0.10 B57.16%
2009-12-31NZ$69.48 M-55.5%
2008-12-31NZ$0.15 B-0.69%
2007-12-31NZ$0.15 B7.67%
2006-12-31NZ$0.14 B24.63%
2005-12-31NZ$0.11 B13.54%
2004-12-31NZ$0.10 B112.42%
2003-12-31NZ$48.58 M-19.22%
2002-12-31NZ$60.14 M65.22%
2001-12-31NZ$36.4 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Agenus
AGEN
NZ$0.40 B-75.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
NZ$50.56 B 2,985.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$224.29 B 13,586.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
NZ$101.34 B 6,084.11%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$198.16 B 11,992.47%๐Ÿ‡ฌ๐Ÿ‡ง UK
GlaxoSmithKline
GSK
NZ$142.77 B 8,612.08%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
NZ$361.39 B 21,952.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
NZ$69.00 B 4,110.86%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Amgen
AMGN
NZ$156.07 B 9,423.55%๐Ÿ‡บ๐Ÿ‡ธ USA